The Role of b-Arrestins in Cancer - Progress in Molecular Biology and Translational Science - page 398

30. Wei Y, Zhang Z, Liao H, et al. Nuclear estrogen receptor-mediated Notch signaling and
GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell pro-
liferation. Oncol Rep . 2012;27(2):504 - 510.
31. Qu JL, Qu XJ, Zhao MF, et al. Gastric cancer exosomes promote tumour cell prolifer-
ation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis . 2009;41
(12):875 - 880.
32. Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH. Role of PI3K and AKT specific
isoforms in ovarian cancer cell migration, invasion and proliferation through the
p70S6K1 pathway. Cell Signal . 2006;18(12):2262 - 2271.
33. Pierce KL, Luttrell LM, Lefkowitz RJ. New mechanisms in heptahelical receptor signal-
ing to mitogen activated protein kinase cascades. Oncogene . 2001;20(13):1532 - 1539.
34. Chun KS, Lao HC, Langenbach R. The prostaglandin E2 receptor, EP2, stimulates
keratinocyte proliferation in mouse skin by G protein-dependent and {beta}-
arrestin1-dependent signaling pathways. J Biol Chem . 2010;285(51):39672 - 39681.
35. Dasgupta P, Rastogi S, Pillai S, et al. Nicotine induces cell proliferation by beta-
arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest . 2006;116
(8):2208 - 2217.
36. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD. Defective
lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci
USA . 2002;99(11):7478 - 7483.
37. Decaillot FM, Kazmi MA, Lin Y, Ray-Saha S, Sakmar TP, Sachdev P. CXCR7/
CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration.
J Biol Chem . 2011;286(37):32188 - 32197.
38. Sun Y, Cheng Z, Ma L, Pei G. Beta-arrestin2 is critically involved in CXCR4-mediated
chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol
Chem . 2002;277(51):49212 - 49219.
39. Girnita L, Shenoy SK, Sehat B, et al. {beta}-Arrestin is crucial for ubiquitination and
down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for
the MDM2 E3 ligase. J Biol Chem . 2005;280(26):24412 - 24419.
40. Girnita L, Shenoy SK, Sehat B, et al. Beta-arrestin and Mdm2 mediate IGF-1 receptor-
stimulated ERK activation and cell cycle progression. J Biol Chem . 2007;282

(15):11329 - 11338.
41. Zou L, Yang R, Chai J, Pei G. Rapid xenograft tumor progression in beta-arrestin1
transgenic mice due to enhanced tumor angiogenesis. FASEB J . 2008;22(2):355 - 364.
42. Li TT, Alemayehu M, Aziziyeh AI, et al. Beta-arrestin/Ral signaling regulates
lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.
Mol Cancer Res . 2009;7(7):1064 - 1077.
43. Shenoy SK, Han S, Zhao YL, et al. Beta-arrestin1 mediates metastatic growth of breast
cancer cells by facilitating HIF-1-dependent VEGF expression. Oncogene . 2012;31
(3):282 - 292.
44. Ge L, Shenoy SK, Lefkowitz RJ, DeFea K. Constitutive protease-activated receptor-2-
mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1
and -2. J Biol Chem . 2004;279(53):55419 - 55424.
45. Wang P, DeFea KA. Protease-activated receptor-2 simultaneously directs beta-
arrestin-1-dependent

inhibition and Galphaq-dependent activation of pho-

sphatidylinositol 3-kinase. Biochemistry . 2006;45(31):9374 - 9385.
46. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Dery O, Bunnett NW. The pro-
liferative and antiapoptotic effects of substance P are facilitated by formation of a beta-
arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA . 2000;97(20):

11086 - 11091.
47. Revankar CM, Vines CM, Cimino DF, Prossnitz ER. Arrestins block G protein-
coupled receptor-mediated apoptosis. J Biol Chem . 2004;279(23):24578 - 24584.